Add like
Add dislike
Add to saved papers

Solvothermal synthesis of Ag hybrid BiPO 4 heterostructures with enhanced photodegradation activity and stability.

In this study, Ag hybrid BiPO4 (Ag/BiPO4 ) heterostructures were synthesized using a solvothermal method. The morphologies and optical properties of the Ag/BiPO4 heterostructures were drastically different from those of BiPO4 and were highly dependent on the AgNO3 :BiPO4 weight percent during the synthesis. The three formulated heterostructures were evaluated for their photocatalytic degradation of methylene blue (MB) under UV light illumination; the 0.5%Ag/BiPO4 heterostructure was observed to result in 99% degradation of MB within 60min, a remarkably higher level of photodegradation activity than the levels caused by TiO2 and BiPO4 . Furthermore, even after use for five cycles of MB degradation, the 0.5%Ag/BiPO4 heterostructure showed no observable loss in photodegradation activity and no change in XRD patterns, demonstrating its chemical and structural stability. According to the results of a systematic experimental investigation, the enhanced photodegradation activity of this Ag/BiPO4 heterostructure could be ascribed to the high position of its valence band and the highly efficient separation of photogenerated electrons and holes. Moreover, hydroxyl radicals and holes were found to be the major reactive species. Successful photodegradation of standard dye solutions, including acid blue 1, methyl orange, fast green, rhodamine B, rhodamine 6G, and MB, in real water samples was demonstrated with the 0.5%Ag/BiPO4 heterostructure, providing clear evidence of its utility for treating waste water containing organic dyes.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app